Answers are grounded in this paper and cite their sources.
Demonstrates crystal phase manipulation in cobalt catalysts to shift selectivity from methane to carbon monoxide in hydrogenation reactions.
Altering the inherent selectivity of catalysts toward the C 1 product is of great significance for enriching the selection of CO 2 directional conversion. Herein, we demonstrate that regulating the crystal phase of cobalt (Co)‐based catalysts enables a dramatic shift from methane (CH 4 ) to carbon monoxide (CO). At 320°C and ambient pressure, the Co with a face‐centered cubic structure (FCC‐Co) predominantly yields CH 4 in CO 2 hydrogenation, achieving 94% of CH 4 selectivity and 53% of CO 2 conversion, while the hexagonal close‐packed structure (HCP‐Co) exhibits exceptional selectivity toward CO, with 96% of CO selectivity and 21% of CO 2 conversion. Multimodal characterizations reveal that compared to FCC‐Co, the lower content of oxygen vacancies and metallic Co 0 over HCP‐Co results in the weak CO 2 /CO adsorption and insufficient hydrogen dissociation, which suppresses the CO→CH 4 step in the CO 2 hydrogenation, thereby redirecting product selectivity toward CO rather than CH 4 . This work highlights crystal phase tailoring of Co‐based catalysts as a viable strategy to regulate product selectivity in CO 2 hydrogenation, offering insights for rational catalyst design in RWGS reactions.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: